JDD March Issue Highlights and Editor Picks
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au …
Below are the issue highlights and Editor Picks for the March issue of JDD!
Papp and Lebwohl review clinical data on the use of biologics in moderate-to-severe psoriasis, identifying which biologics may offer the quickest results in Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.
In Clinical Insights About Onychomycosis and Its Treatment: A Consensus, au … Continue reading "JDD March Issue Highlights and Editor Picks"
Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor.
This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to the "cosmetic elegance" of seborrhe … 
When a patient reveals they went online for health information, it’s tempting for a clinician to inwardly groan. Fears of self-diagnosis or misinformation about diagnosed conditions can make clinicians concerned when patients seek medical information through online forums and social media. Yet these virtual communities are incredibly popular, most notably Reddit and its discussion forums.
A … 
Dermatologists have several prescription treatment options for hair loss, including minoxidil, spironolactone, finasteride, and latanoprost. Yet despite the commonality of hair loss, insurance coverage of hair loss treatments is rare. An editorial published in the August Journal of Drugs in Dermatology assesses the differences in insurance coverage of these hair loss medications.
I interviewed …